Corona Remedies IPO
Corona Remedies Limited (CORONA) · mainboard IPO on NSE and BSE · 100% Book Building. Listed on 15 December 2025.
Issue details
Listing day
Back-tested estimate (from a model that had only seen earlier years' IPOs): listing gain +69.8% (likely range +40% to +96%), day's high +69.8%, chance of a gain 92%. Actual: +38.4% at the open, +41.0% at the high.
Subscription status
| Category | Shares offered | Shares bid for | Subscribed | |
|---|---|---|---|---|
| QIB (institutions) | 12,88,732 | 35,89,39,448 | 279x | |
| NII (HNI) total | 9,66,549 | 20,18,97,066 | 209x | |
| Big NII (above ₹10 lakh) | 6,44,366 | 15,07,93,356 | 234x | |
| Small NII (₹2-10 lakh) | 3,22,183 | 5,11,03,710 | 159x | |
| Retail | 22,55,281 | 6,48,02,038 | 28.7x | |
| Employees | 61,320 | 9,02,888 | 14.7x | |
| Total | 45,71,882 | 62,65,41,440 | 137x |
Bids on NSE and BSE together, as published by NSE, as of 10 Dec 2025, 07:00 PM. Shares offered exclude the anchor portion. 9% of all shares bid for were at the cut-off price.
Past IPOs with similar demand
Earlier mainboard IPOs whose QIB, NII and retail subscription and size were closest to Corona Remedies's, and how they listed.
| IPO | QIB | NII | Retail | Total | Size | Listing gain | Day high |
|---|---|---|---|---|---|---|---|
| Data Patterns (India)Dec 2021 | 191x | 254x | 23.1x | 120x | ₹587 Cr | +46.3% | +47.7% |
| GNG ElectronicsJul 2025 | 266x | 228x | 46.8x | 148x | ₹479 Cr | +49.8% | +51.6% |
| Laxmi Organic IndustriesMar 2021 | 175x | 218x | 20.1x | 107x | ₹605 Cr | +19.6% | +34.3% |
| DEE Development EngineersJun 2024 | 202x | 144x | 23.4x | 99.6x | ₹431 Cr | +67.0% | +80.2% |
| Unimech Aerospace and ManufacturingDec 2024 | 318x | 264x | 56.7x | 175x | ₹527 Cr | +86.0% | +89.2% |
| Indigo PaintsJan 2021 | 190x | 263x | 15.9x | 117x | ₹1,170 Cr | +75.0% | +110.0% |
Lead managers and their listing record
| Book running lead manager | Mainboard IPOs since 2019 | Avg listing gain | Listed at a premium |
|---|---|---|---|
| JM Financial | 109 | +22.8% | 75% |
| IIFL Capital Services | 94 | +19.3% | 71% |
| Kotak Mahindra Capital Company | 83 | +20.8% | 76% |
Offer documents (NSE)
Frequently asked
What is the Corona Remedies IPO price band and lot size? ₹1,008–1,062 per share, with a lot of 14 shares, so the smallest retail bid is ₹14,868.
How many times has it been subscribed? 137x overall: QIB 279x, NII 209x, retail 28.7x, employees 14.7x.
How did it list? It opened at ₹1,470, +38.4% against the issue price of ₹1,062, and closed its first day +35.4%.